lncrna + mrna human gene expression microarray v4.0 platform (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
lncrna + mrna human gene expression microarray v4.0 platform
Lncrna + Mrna Human Gene Expression Microarray V4.0 Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lncrna+expression+microarray/pm36646024-58-5-4
Average 90 stars, based on 1 article reviews
Lncrna + Mrna Human Gene Expression Microarray V4.0 Platform, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lncrna+expression+microarray/pm36646024-58-5-4
Average 90 stars, based on 1 article reviews
lncrna + mrna human gene expression microarray v4.0 platform - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Microarray:Article Title: Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction. Article Snippet: Sacubitril/valsartan has a noteworthy advantage in improving ventricular remodelling, as well as reducing cardiovascular mortality and the rate of heart failure (HF) readmission.. However, clinically, some patients with HF still have low sensitivity to sacubitril/valsartan, indicating sacubitril/valsartan resistance (SVR).. A total of 46 patients with HF after AMI (23 SVR and 23 non-sacubitril/valsartan resistance (NSVR)) were selected. Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: Thus, it was considered worthy of investigation to define which factors lead to the overdevelopment of placentas and the occurrence of macrosomia. lncrnas are non‐coding rnas with a length of >200 nucleotides, and are related to numerous pregnancy compli‐ cations, including gestational diabetes (37). in the present study, the expression profiles of lncRNAs in the placentas of pregnant women with ndFMS were investigated using an Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: The primer sequences for rT‐qPcr are listed in Table i. lncRNA microarray analysis. a total of eight samples from the ndFMS group and eight samples from the control group were prepared into two merged rna samples, one per each group, for microarray screening. rna labeling and microarray hybridization were performed according to the manufacturer's protocol using the Agilent Article Title: Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Article Snippet: Screening cancer genomes has provided an in-depth characterization of genetic variants such as copy number variations (CNVs) and gene expression changes of non-coding transcripts.. Single-dimensional experiments are often designed to differentiate a patient cohort into various sets with the aim of identifying molecular changes among groups; however, this may be inadequate to decipher the causal relationship between molecular signatures in individual patients.. To overcome this challenge with respect to personalized medicine, we implemented a patient-specific multi-dimensional integrative approach to uncover coherent signals from multiple independent platforms. Hybridization:Article Title: Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction. Article Snippet: Sacubitril/valsartan has a noteworthy advantage in improving ventricular remodelling, as well as reducing cardiovascular mortality and the rate of heart failure (HF) readmission.. However, clinically, some patients with HF still have low sensitivity to sacubitril/valsartan, indicating sacubitril/valsartan resistance (SVR).. A total of 46 patients with HF after AMI (23 SVR and 23 non-sacubitril/valsartan resistance (NSVR)) were selected. Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: Thus, it was considered worthy of investigation to define which factors lead to the overdevelopment of placentas and the occurrence of macrosomia. lncrnas are non‐coding rnas with a length of >200 nucleotides, and are related to numerous pregnancy compli‐ cations, including gestational diabetes (37). in the present study, the expression profiles of lncRNAs in the placentas of pregnant women with ndFMS were investigated using an Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: The primer sequences for rT‐qPcr are listed in Table i. lncRNA microarray analysis. a total of eight samples from the ndFMS group and eight samples from the control group were prepared into two merged rna samples, one per each group, for microarray screening. rna labeling and microarray hybridization were performed according to the manufacturer's protocol using the Agilent Article Title: Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Article Snippet: Screening cancer genomes has provided an in-depth characterization of genetic variants such as copy number variations (CNVs) and gene expression changes of non-coding transcripts.. Single-dimensional experiments are often designed to differentiate a patient cohort into various sets with the aim of identifying molecular changes among groups; however, this may be inadequate to decipher the causal relationship between molecular signatures in individual patients.. To overcome this challenge with respect to personalized medicine, we implemented a patient-specific multi-dimensional integrative approach to uncover coherent signals from multiple independent platforms. Purification:Article Title: Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction. Article Snippet: Sacubitril/valsartan has a noteworthy advantage in improving ventricular remodelling, as well as reducing cardiovascular mortality and the rate of heart failure (HF) readmission.. However, clinically, some patients with HF still have low sensitivity to sacubitril/valsartan, indicating sacubitril/valsartan resistance (SVR).. A total of 46 patients with HF after AMI (23 SVR and 23 non-sacubitril/valsartan resistance (NSVR)) were selected. Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: Thus, it was considered worthy of investigation to define which factors lead to the overdevelopment of placentas and the occurrence of macrosomia. lncrnas are non‐coding rnas with a length of >200 nucleotides, and are related to numerous pregnancy compli‐ cations, including gestational diabetes (37). in the present study, the expression profiles of lncRNAs in the placentas of pregnant women with ndFMS were investigated using an Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: The primer sequences for rT‐qPcr are listed in Table i. lncRNA microarray analysis. a total of eight samples from the ndFMS group and eight samples from the control group were prepared into two merged rna samples, one per each group, for microarray screening. rna labeling and microarray hybridization were performed according to the manufacturer's protocol using the Agilent Article Title: Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Article Snippet: Screening cancer genomes has provided an in-depth characterization of genetic variants such as copy number variations (CNVs) and gene expression changes of non-coding transcripts.. Single-dimensional experiments are often designed to differentiate a patient cohort into various sets with the aim of identifying molecular changes among groups; however, this may be inadequate to decipher the causal relationship between molecular signatures in individual patients.. To overcome this challenge with respect to personalized medicine, we implemented a patient-specific multi-dimensional integrative approach to uncover coherent signals from multiple independent platforms. Expressing:Article Title: Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction. Article Snippet: Sacubitril/valsartan has a noteworthy advantage in improving ventricular remodelling, as well as reducing cardiovascular mortality and the rate of heart failure (HF) readmission.. However, clinically, some patients with HF still have low sensitivity to sacubitril/valsartan, indicating sacubitril/valsartan resistance (SVR).. A total of 46 patients with HF after AMI (23 SVR and 23 non-sacubitril/valsartan resistance (NSVR)) were selected. Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: Thus, it was considered worthy of investigation to define which factors lead to the overdevelopment of placentas and the occurrence of macrosomia. lncrnas are non‐coding rnas with a length of >200 nucleotides, and are related to numerous pregnancy compli‐ cations, including gestational diabetes (37). in the present study, the expression profiles of lncRNAs in the placentas of pregnant women with ndFMS were investigated using an Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: The primer sequences for rT‐qPcr are listed in Table i. lncRNA microarray analysis. a total of eight samples from the ndFMS group and eight samples from the control group were prepared into two merged rna samples, one per each group, for microarray screening. rna labeling and microarray hybridization were performed according to the manufacturer's protocol using the Agilent Article Title: Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Article Snippet: Screening cancer genomes has provided an in-depth characterization of genetic variants such as copy number variations (CNVs) and gene expression changes of non-coding transcripts.. Single-dimensional experiments are often designed to differentiate a patient cohort into various sets with the aim of identifying molecular changes among groups; however, this may be inadequate to decipher the causal relationship between molecular signatures in individual patients.. To overcome this challenge with respect to personalized medicine, we implemented a patient-specific multi-dimensional integrative approach to uncover coherent signals from multiple independent platforms. Labeling:Article Title: Comprehensive analysis of the RNA transcriptome expression profiles and construction of the ceRNA network in heart failure patients with sacubitril/valsartan therapeutic heterogeneity after acute myocardial infarction. Article Snippet: Sacubitril/valsartan has a noteworthy advantage in improving ventricular remodelling, as well as reducing cardiovascular mortality and the rate of heart failure (HF) readmission.. However, clinically, some patients with HF still have low sensitivity to sacubitril/valsartan, indicating sacubitril/valsartan resistance (SVR).. A total of 46 patients with HF after AMI (23 SVR and 23 non-sacubitril/valsartan resistance (NSVR)) were selected. Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: Thus, it was considered worthy of investigation to define which factors lead to the overdevelopment of placentas and the occurrence of macrosomia. lncrnas are non‐coding rnas with a length of >200 nucleotides, and are related to numerous pregnancy compli‐ cations, including gestational diabetes (37). in the present study, the expression profiles of lncRNAs in the placentas of pregnant women with ndFMS were investigated using an Article Title: Downregulation of lncRNA USP2‑AS1 in the placentas of pregnant women with non‑diabetic fetal macrosomia promotes trophoblast cell proliferation. Article Snippet: The primer sequences for rT‐qPcr are listed in Table i. lncRNA microarray analysis. a total of eight samples from the ndFMS group and eight samples from the control group were prepared into two merged rna samples, one per each group, for microarray screening. rna labeling and microarray hybridization were performed according to the manufacturer's protocol using the Agilent Article Title: Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Article Snippet: Screening cancer genomes has provided an in-depth characterization of genetic variants such as copy number variations (CNVs) and gene expression changes of non-coding transcripts.. Single-dimensional experiments are often designed to differentiate a patient cohort into various sets with the aim of identifying molecular changes among groups; however, this may be inadequate to decipher the causal relationship between molecular signatures in individual patients.. To overcome this challenge with respect to personalized medicine, we implemented a patient-specific multi-dimensional integrative approach to uncover coherent signals from multiple independent platforms. |
